Mesoblast (MESO) Income from Continuing Operations (2016 - 2023)
Historic Income from Continuing Operations for Mesoblast (MESO) over the last 9 years, with Q2 2023 value amounting to -$22.0 million.
- Mesoblast's Income from Continuing Operations fell 56.79% to -$22.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$82.2 million, marking a year-over-year increase of 1068.55%. This contributed to the annual value of -$102.1 million for FY2025, which is 1612.85% down from last year.
- According to the latest figures from Q2 2023, Mesoblast's Income from Continuing Operations is -$22.0 million, which was down 56.79% from -$18.6 million recorded in Q1 2023.
- In the past 5 years, Mesoblast's Income from Continuing Operations ranged from a high of -$7.4 million in Q3 2019 and a low of -$29.4 million during Q1 2019
- Over the past 5 years, Mesoblast's median Income from Continuing Operations value was -$22.4 million (recorded in 2021), while the average stood at -$22.5 million.
- In the last 5 years, Mesoblast's Income from Continuing Operations surged by 6455.07% in 2019 and then plummeted by 25064.72% in 2020.
- Mesoblast's Income from Continuing Operations (Quarter) stood at -$29.1 million in 2019, then rose by 12.29% to -$25.5 million in 2020, then dropped by 2.2% to -$26.1 million in 2021, then rose by 5.66% to -$24.6 million in 2022, then grew by 10.84% to -$22.0 million in 2023.
- Its Income from Continuing Operations stands at -$22.0 million for Q2 2023, versus -$18.6 million for Q1 2023 and -$24.6 million for Q4 2022.